Tekla Life Sciences Investors logo
Tekla Life Sciences Investors HQL
$ 13.86 0.43%

Tekla Life Sciences Investors Operating Expenses 2011-2024 | HQL

Annual Operating Expenses Tekla Life Sciences Investors

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 1.14 M 1.16 M 1.26 M 679 K 397 K 500 K 590 K 950 K 1.35 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.35 M 397 K 891 K